A future for regulatory science in the European Union: the European Medicines Agency’s strategy

Nature Reviews Drug Discovery

 4 May 2020 - After 3 years of co-design with stakeholders and EU regulatory partners, the European Medicines Agency’s Regulatory Science to 2025 strategy has been finalised. 

This article highlights the core recommendations that stakeholders deem most significant to advance evidence generation.

Read Nature Reviews Drug Discovery Commentary

Michael Wonder

Posted by:

Michael Wonder